liver-transplantation

Documents about liver-transplantation

• Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®#802957ClinicalTrials.gov
• Addiction Intervention in Liver Transplantation Candidates#867475ClinicalTrials.gov
• Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma#917028ClinicalTrials.gov
• Lifestyle Intervention For Liver Transplantation#123608ClinicalTrials.gov
• AGRA Before and After Liver Transplantation#869567ClinicalTrials.gov
• Transoesophageal Echocardiography in Liver Transplantation#915644ClinicalTrials.gov
• Developing Prediction Models for Allograft Failure After Liver Transplantation#851633ClinicalTrials.gov
• Normothermic Liver Preservation Trial#852303ClinicalTrials.gov
• Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria#811003ClinicalTrials.gov
• Systemic Variables in the Saliva of Children Undergoing Liver Transplantation#806723ClinicalTrials.gov
• Effect of Sham Feeding on Postoperative Ileus After Elective Liver Transplantation#872174ClinicalTrials.gov
• Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel#844317ClinicalTrials.gov
• Liver Transplantation After ex Vivo Liver Perfusion#300286ClinicalTrials.gov
• Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)#1000628HAL (France)
• Liver transplantation in unresectable intrahepatic cholangiocarcinoma following neoadjuvant chemotherapy and SIRT#317476HAL (France)
• Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation#863089ClinicalTrials.gov
• Delayed Infusion of DCreg in Living Donor Liver Transplantation#912183ClinicalTrials.gov
• Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant#850972ClinicalTrials.gov
• Living Donor Liver Transplantation for CRC Liver Metastases#992984ClinicalTrials.gov
• Table 2_Gut microbiota reconstruction after liver transplantation and its association with early postoperative infections in patients with liver failure.docx#266434Figshare
• Table 1_Gut microbiota reconstruction after liver transplantation and its association with early postoperative infections in patients with liver failure.docx#266435Figshare
• Unknown Cause of Acute Liver Failure#866399ClinicalTrials.gov
• Feasibility and Effectiveness of Liver Transplantation following Immunotherapy in Patients with Hepatocellular Carcinoma#261988HAL (France)
• Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation#852760ClinicalTrials.gov
• Safety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)#899727ClinicalTrials.gov
• Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation#900882ClinicalTrials.gov
• Prehabilitation for Patients Awaiting Liver Transplantation#992427ClinicalTrials.gov
• Envarsus XL Immunosuppression Following Liver Transplantation#901499ClinicalTrials.gov
• Liver Immune Tolerance Marker Utilization Study#908175ClinicalTrials.gov
• LEOPARD Prospective Validation Cohort 1#832784ClinicalTrials.gov
• Quality of Life in Pediatric Transplant Patients#1007075ClinicalTrials.gov
• Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)#966674ClinicalTrials.gov
• Omega 3 Lipid Emulsions and Liver Transplantation#833691ClinicalTrials.gov
• The Role of Biomarkers in the Early Detection of Acute Kidney Injury Induced by Liver Transplantation#841873ClinicalTrials.gov
• The Validity of Central Venous to Arterial Co2 Difference During Living Donor Liver Transplantation#866463ClinicalTrials.gov
• Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation#995631ClinicalTrials.gov
• Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.#1007607ClinicalTrials.gov
• Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation#829131ClinicalTrials.gov
• Resection And Partial Liver Segmental Transplantation With Delayed Total Hepatectomy#828567ClinicalTrials.gov
• LT for Unresectable Colorectal Liver Metastasis#861285ClinicalTrials.gov
• Mycophenolate Mofetil Maintenance Therapy for Liver Transplantation#993384ClinicalTrials.gov
• Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)#980269ClinicalTrials.gov
• Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients#833817ClinicalTrials.gov
• High-Flow Nasal Cannula Versus Conventional Oxygen Therapy After Extubation in Liver Transplantation#830067ClinicalTrials.gov
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection#831499ClinicalTrials.gov
• Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.#859454ClinicalTrials.gov
• Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation#892531ClinicalTrials.gov
• YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation#979696ClinicalTrials.gov
• Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization#894060ClinicalTrials.gov
• Reconstructing the Self After Liver Transplantation#108847PhilArchive